Serial 88693707
Live / Registered — Registered (as of 22 Jun 2021)
What this means for you
Registered since 22 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88693707
- Registration number
- 6392382
- Mark type
- Design / logo
- Filed
- 15 Nov 2019
- Published for opposition
- 06 Apr 2021
- Registered
- 22 Jun 2021
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as and X-ray contrast reagents
Owner
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- Slayback Pharma Limited Liability Company, Princeton, NJ, US
- Slayback Pharma Limited Liability Company, Princeton, NJ, US
- Slayback Pharma Limited Liability Company, Princeton, NJ, US
Prosecution history
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Mar 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jul 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Jul 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Apr 2021 — PUBLISHED FOR OPPOSITION
- 17 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Feb 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED